The agent of human granulocytic ehrlichiosis (HGE) is an emerging tick-borne pathogen that resides in neutrophils and can be cultured in a promyelocytic (HL-60) cell line. In response to microbes, polymorphonuclear leukocytes normally activate the NADPH oxidase enzyme complex and generate superoxide anion (O2). However, HL-60 cells infected with HGE bacteria did not produce O2 upon activation with PMA. RT-PCR demonstrated that HGE organisms inhibited mRNA expression of a single component of NADPH oxidase, gp91phox, and FACS analysis showed that plasma membrane-associated gp91phox protein was reduced on the infected cells. Infection with HGE organisms also decreased gp91phox mRNA levels in splenic neutrophils in a murine model of HGE, demonstrating this phenomenon in vivo. Therefore, HGE bacteria repress the respiratory burst by down-regulating gp91phox, the first direct inhibition of NADPH oxidase by a pathogen.

Human granulocytic ehrlichiosis (HGE)3 is a newly described tick-borne disease that is caused by an obligate intracellular pathogen with a tropism for neutrophils (1, 2). Infection is often accompanied by fever, myalgia, and leukopenia and can sometimes result in death (1, 2). Morulae containing HGE bacteria can be found within the cytoplasm of bloodstream polymorphonuclear neutrophils (PMNs) during acute disease (1). Bone marrow progenitors (3), HL-60 cells (a promyelocytic tumor cell line), and C3H/HeN mice can become infected with the HGE agent, facilitating the in vitro and in vivo study of this pathogen (4, 5).

Neutrophils are primary effector cells in host defenses (6), and the respiratory burst that is initiated by NADPH oxidase plays a major role in microbial eradication (7). In resting cells, the four components of the inactive oxidase are unassembled: p47phox and p67phox are present in the cytosol and gp91phox and p22phox are in the plasma membrane (8, 9, 10). During activation, p47phox and p67phox, along with Rac2, translocate to the plasma membrane, where they associate with flavocytochrome b558, the key membrane-bound component that is composed of gp91phox and p22phox (7, 11). Formation of the complex is essential for superoxide anion (O2) generation. Defects in oxidase activity, as demonstrated in chronic granulomatous disease, result in increased susceptibility to various infectious agents (12, 13). To survive, the agent of HGE must have evolved strategies to persist in this hostile environment. Indeed, HGE organisms reside in vacuoles that do not fuse with lysosomes, providing insight into one such tactic (14, 15). We now investigate the effect of HGE bacteria on the respiratory burst because of the paradox that this organism preferentially persists within neutrophils.

HL-60 cells were cultured in Dulbecco’s medium with 20% FCS at 37°C in 5% CO2 and infected with the HGE agent (4, 5). At 5 days, >90% of the cells contained morulae. In some assays, HL-60 cells were exposed to heat-killed HGE bacteria for 24 h or to supernatant (10 ml of supernatant from Ehrlichia-infected HL-60 cells) for 5 days. HL-60 cells (2 × 105/ml) were incubated at 37°C in 5% CO2 with 1 μM retinoic acid and cultured for 6 days for maximum differentiation (3, 16, 17). Superoxide anion was measured in both control and infected (both uninduced and retinoic acid-induced) HL-60 cells. In some assays, cells were also treated with IFN-γ (1000 U/2 × 105 cells) for 48 h before the assay and then centrifuged at 500 × g for 10 min at 4°C to harvest the cells (18). In all assays, PMA (200 ng/ml) was used as a stimulating agent along with luminol and an enhancer of chemiluminescence, and superoxide anion was expressed in relative luminometer units (RLU). For the studies with HL-60 cells induced with IFN-γ, a Lumat LB 9501 luminometer (Wallac, Gaithersburg, MD) was used, and for the retinoic acid-differentiated HL-60 cells, a TD-20/20 luminometer (Promega, Madison, WI) was used. The RLU for the two machines are different and should not be directly compared.

cDNA was prepared from 5 μg of total RNA using random primers, and PCR amplification was then performed (19). The reaction mixture contained 5 μl of 10× PCR buffer with MgCl2, 1 μl of 10 mM dNTP, 4 μl of 20 μM primers, 0.5 μl of Taq polymerase (5 U/μl), and 2 μl of cDNA. For semiquantitative PCR, serial dilutions of the template were used. The primers were gp91phox (403 bp, 5′-GCTGTTCAATGCTTGTGGCT-3′, 5′-TCTCCTCATCATGGTGCACA-3′), p22phox (325 bp, 5′-GT TTGTTTTGTGCCTGCTGGAGT-3′, 5′-TGGGCGGCTGCTTGATGGT-3′), p67phox (726 bp, 5′-CGAGGGAACCAGCTGATAGA-3′, 5′-CATGGGAACACTGAGCTTCA-3′), p47phox (767 bp, 5′-ACCCAGCCAGCACTATGTGT-3′, 5′-AGTAGCCTGTGACGTCGTCT-3′), HGE 16S rRNA (4) (250 bp, 5′-TGTAGGCGGTTCGGTAAGTTAAAG-3′, 5′-GCACTCATCGTTTACAGCGTG-3′), and β-actin (300 bp, 5′-AGCGGGAAATCGTGCGTG-3′, 5′-CAGGGTACATGGTGGTGCC-3′).

Plasma membrane-associated gp91phox protein was determined using mAb 7D5. HL-60 cells (107/ml), both control and infected (treated with or without IFN-γ), were resuspended in PBS/1% FCS, and gp91phox protein was detected with mAb 7D5 and a fluorescein-conjugated goat-anti-mouse-IgG Ab (20). HL-60 cells stained with a control IgG1 mAb of the same isotype as mAb 7D5 were used for comparison and did not demonstrate binding (data not shown).

Six-week-old C3H/HeN mice were housed in filter-framed cages. A volume of 0.1 ml of blood from an Ehrlichia-infected SCID mouse was used to inoculate groups of five C3H mice (4, 21). Mice were sacrificed at 2 and 8 days, and splenic neutrophils were used to examine gp91phox expression. Spleen cells from five mice were pooled and plated in flasks in RPMI with 10% FBS at 37°C, 5% CO2. Nonadherent cells were removed after 1 h and subjected to negative selection using mouse anti-CD4, anti-CD8a, anti-B220, and anti-Pan-NK cells (PharMingen, San Diego, CA) and goat-anti-mouse-IgG bound to magnetic beads (Perspective Biosystems, Cambridge, MA). A total of 2 × 106 neutrophils were used to isolate RNA that was then reverse transcribed to obtain cDNA. The primers for murine gp91phox were 5′-GTCAAGTGCCCCAAGGTATCCA-3′ and 5′-TTGTAGCTGAGGAAGTTGGC-3′.

The production of O2 in HL-60 cells infected with the HGE agent was first examined (Fig. 1). As expected, some O2 was detected in HL-60 cells activated with PMA (13). In contrast, HL-60 cells infected with Ehrlichia failed to produce O2 (Fig. 1). As a control, Escherichia coli did not inhibit O2 production (not shown). Cells were then stimulated with IFN-γ to increase NADPH oxidase activity. IFN-γ induced O2 levels in uninfected HL-60 cells but not in the Ehrlichia-infected cells (Fig. 1). Similar results were observed with HL-60 cells terminally differentiated into neutrophils with retinoic acid (Fig. 2). These data show that HGE bacteria inhibit the respiratory burst under a variety of conditions.

FIGURE 1.

Superoxide anion formation in uninfected and Ehrlichia-infected HL-60 cells using a chemiluminescence assay. PMA was used as an activating agent in all assays. Data are presented in RLU. Results are the mean ± SDs of three experiments.

FIGURE 1.

Superoxide anion formation in uninfected and Ehrlichia-infected HL-60 cells using a chemiluminescence assay. PMA was used as an activating agent in all assays. Data are presented in RLU. Results are the mean ± SDs of three experiments.

Close modal
FIGURE 2.

Time-course of superoxide anion formation in uninfected and Ehrlichia-infected HL-60 cells differentiated to neutrophils using retinoic acid. Cells were incubated with PMA for different time periods (0.5, 1, 2, 3, and 4 h), and O2 was expressed in RLU. Results are the mean ± SDs of three studies. ○, Infected cells; •, uninfected cells.

FIGURE 2.

Time-course of superoxide anion formation in uninfected and Ehrlichia-infected HL-60 cells differentiated to neutrophils using retinoic acid. Cells were incubated with PMA for different time periods (0.5, 1, 2, 3, and 4 h), and O2 was expressed in RLU. Results are the mean ± SDs of three studies. ○, Infected cells; •, uninfected cells.

Close modal

To explore the mechanism by which O2 was suppressed, the influence of HGE bacteria on the expression of genes encoding the multicomponent NADPH oxidase complex was examined by RT-PCR (Fig. 3). Similar levels of p22phox, p47phox, and p67phox mRNA were apparent in control and infected cells (Fig. 3,a, lanes 1 and 2). In contrast, gp91phox mRNA was not present in HL-60 cells infected with live Ehrlichia. Infection with HGE bacteria also inhibited the expression of gp91phox mRNA in HL-60 cells that were differentiated into neutrophils using retinoic acid (Fig. 3,a, lanes 3 and 4). gp91phox mRNA expression was not affected when HL-60 cells were exposed to heat-killed organisms, or incubated with medium from Ehrlichia-infected HL-60 cells (Fig. 3,b), demonstrating that dead bacteria or a soluble factor secreted by the HGE agent were not capable of down-regulating gp91phox. Cells were then induced with IFN-γ to determine whether HGE bacteria could alter gp91phox mRNA levels under conditions of maximal stimulation (18). As expected, IFN-γ markedly increased gp91phox mRNA expression (Fig. 4,a) in uninfected HL-60 cells. Lower levels of gp91phox mRNA were detected in the Ehrlichia-infected cells in response to IFN-γ than in uninfected cells. Serial dilution PCR analysis indicated that gp91phox mRNA was evident in Ehrlichia-infected cells when the cDNA template was used at a 1:4 dilution and in control cells at a 1:32 dilution (not shown). Ehrlichia mRNA was detected in these cells, verifying that the bacteria persisted (Fig. 4,b). However, this lower level of gp91phox transcription could not reverse the respiratory burst arrest by Ehrlichia (Fig. 1). Therefore, additional Ehrlichia-induced effects must also contribute to respiratory burst inhibition.

FIGURE 3.

Effect of infection with the HGE agent on the expression of mRNA for NADPH oxidase components. a, RT-PCR using primers for p22phox, p47phox, p67phox, and gp91phox with uninfected HL-60 cells (lane 1), HGE bacteria-infected HL-60 cells (lane 2), uninfected retinoic acid-differentiated HL-60 cells (lane 3), and HGE bacteria-infected retinoic acid-differentiated HL-60 cells (lane 4). b, Expression of gp91phox mRNA in HL-60 cells (lane 1), HL-60 cells treated with heat-killed HGE organisms (lane 2), and HL-60 cells grown in medium from Ehrlichia-infected HL-60 cells (lane 3). β-actin levels were measured as a control. One of five experiments with similar results is shown.

FIGURE 3.

Effect of infection with the HGE agent on the expression of mRNA for NADPH oxidase components. a, RT-PCR using primers for p22phox, p47phox, p67phox, and gp91phox with uninfected HL-60 cells (lane 1), HGE bacteria-infected HL-60 cells (lane 2), uninfected retinoic acid-differentiated HL-60 cells (lane 3), and HGE bacteria-infected retinoic acid-differentiated HL-60 cells (lane 4). b, Expression of gp91phox mRNA in HL-60 cells (lane 1), HL-60 cells treated with heat-killed HGE organisms (lane 2), and HL-60 cells grown in medium from Ehrlichia-infected HL-60 cells (lane 3). β-actin levels were measured as a control. One of five experiments with similar results is shown.

Close modal
FIGURE 4.

Effect of IFN-γ on the expression of gp91phox mRNA in uninfected and Ehrlichia-infected HL-60 cells. a, RT-PCR analysis of gp91phox mRNA expression in HL-60 cells (lane 1), IFN-γ-stimulated HL-60 cells (lane 2), Ehrlichia-infected HL-60 cells (lane 3), and IFN-γ-stimulated Ehrlichia-infected HL-60 cells (lane 4). b, RT-PCR showing HGE bacterial mRNA (16S rRNA primers) load in unstimulated (lane 1) and IFN-γ-stimulated HL-60 cells (lane 2). One of four experiments with similar results is shown.

FIGURE 4.

Effect of IFN-γ on the expression of gp91phox mRNA in uninfected and Ehrlichia-infected HL-60 cells. a, RT-PCR analysis of gp91phox mRNA expression in HL-60 cells (lane 1), IFN-γ-stimulated HL-60 cells (lane 2), Ehrlichia-infected HL-60 cells (lane 3), and IFN-γ-stimulated Ehrlichia-infected HL-60 cells (lane 4). b, RT-PCR showing HGE bacterial mRNA (16S rRNA primers) load in unstimulated (lane 1) and IFN-γ-stimulated HL-60 cells (lane 2). One of four experiments with similar results is shown.

Close modal

gp91phox protein expression was then examined to determine whether HGE bacteria influenced formation of the NADPH oxidase complex on the plasma membrane. HL-60 cells were analyzed by FACS using mAb 7D5, which recognizes an extracytoplasmic epitope of the gp91phox protein (22). mAb 7D5 bound to uninfected but not to Ehrlichia-infected HL-60 cells (Fig. 5). HL-60 cells further stimulated with IFN-γ demonstrated a large increase in mAb 7D5 binding, and only very weak mAb 7D5 reactivity was observed in Ehrlichia-infected, IFN-γ-induced cells (Fig. 5). Therefore, infection with the HGE agent reduced gp91phox protein on the plasma membrane.

FIGURE 5.

Flow cytometric analysis of plasma membrane associated gp91phox protein expression in control and HGE-infected HL-60 cells. HL-60 cells (control or infected) were treated with or without IFN-γ and then probed with mAb 7D5. One of four experiments with similar results is shown.

FIGURE 5.

Flow cytometric analysis of plasma membrane associated gp91phox protein expression in control and HGE-infected HL-60 cells. HL-60 cells (control or infected) were treated with or without IFN-γ and then probed with mAb 7D5. One of four experiments with similar results is shown.

Close modal

Inhibition of gp91phox mRNA expression by the HGE agent was then assessed in a murine model of granulocytic ehrlichiosis (4). As expected, morulae were evident during the first weeks of infection (4) and observed in 12% of the splenic neutrophils on 8 days. At 2 and 8 days, splenic neutrophils were examined for gp91phox expression (Fig. 6). gp91phox mRNA levels were lower in the infected tissue than in uninfected controls. gp91phox mRNA could be detected when the cDNA template was used at a dilution of 1:100 (barely visible) and 1:400 in mice infected with Ehrlichia for 2 and 8 days, respectively, and at a dilution of 1:1600 in uninfected mice. The disproportionate degree of suppression may be due to an Ehrlichia burden in some neutrophils that is too low for direct visualization. These data demonstrate that down-regulation of gp91phox mRNA levels also occurs in vivo.

FIGURE 6.

The influence on HGE bacteria on gp91phox mRNA expression in vivo. RT-PCR analysis of expression of gp91phox mRNA in the splenic neutrophils of groups of five uninfected C3H mice, and mice infected with Ehrlichia for 2 days and 8 days are shown. β-actin mRNA levels were measured as a control. cDNAs from the neutrophils were serially diluted, and PCR was performed. Dilutions: lane 1, 1:1; lane 2, 1:10; lane 3, 1:100; lane 4, 1:200; lane 5, 1:400; lane 6, 1:800; lane 7, 1:1600; and lane 8, 1:3200.

FIGURE 6.

The influence on HGE bacteria on gp91phox mRNA expression in vivo. RT-PCR analysis of expression of gp91phox mRNA in the splenic neutrophils of groups of five uninfected C3H mice, and mice infected with Ehrlichia for 2 days and 8 days are shown. β-actin mRNA levels were measured as a control. cDNAs from the neutrophils were serially diluted, and PCR was performed. Dilutions: lane 1, 1:1; lane 2, 1:10; lane 3, 1:100; lane 4, 1:200; lane 5, 1:400; lane 6, 1:800; lane 7, 1:1600; and lane 8, 1:3200.

Close modal

Diverse pathogens, including Legionella pneumophila, Toxoplasma gondii, Chlamydia, Ehrlichia risticii (which infects macrophages), Entamoeba histolytica, and Leishmania, have been shown to inhibit the respiratory burst; however, the mechanism(s) is (are) not known (23, 24, 25, 26, 27, 28). Suppression of NADPH oxidase activity by down-regulating expression of a critical subunit of the enzyme complex by HGE bacteria represents a new mechanism by which microbes circumvent the oxidant-generating respiratory burst. It is intriguing that Ehrlichia targets the gene, gp91phox, which is associated with chronic granulomatous disease (12), and suggests that HGE bacteria induces a transient state in which the host may be more susceptible to secondary infections. Understanding the biological basis of respiratory burst arrest by pathogens should facilitate the development of new strategies to prevent infectious diseases and modify inflammatory responses.

We thank Sankar Ghosh for help with the luminometric assays and Debbie Beck for technical assistance.

1

This work was supported by grants from the National Institutes of Health, Brown-Coxe Fellowship Program, and a gift from SmithKline Beecham Biologicals. E.F. is the recipient of a Clinical-Scientist Award in Translational Research from the Burroughs Wellcome Fund.

3

Abbreviations used in this paper: HGE, human granulocytic ehrlichiosis; PMN, polymorphonuclear neutrophil; RLU, relative luminometer unit.

1
Dumler, J. S., J. S. Bakken.
1998
. Human ehrlichiosis: newly recognized infections transmitted by ticks.
Annu. Rev. Med.
49
:
201
2
Walker, D. J., J. S. Dumler.
1997
. Human monocytic and granulocytic ehrlichiosis.
Arch. Pathol. Lab. Med.
121
:
785
3
Klein, M. B., J. S. Miller, C. M. Nelson, J. L. Goodman.
1997
. Primary bone marrow progenitors of both granulocytic and monocytic lineages are susceptible to infection with the agent of human granulocytic ehrlichiosis.
J. Infect. Dis.
176
:
1405
4
Sun, W., J. Ijdo, S. R. Telford, E. Hodzic, Y. Zhang, S. W. Barthold, E. Fikrig.
1997
. Immunization against the agent of human granulocytic ehrlichiosis in a murine model.
J. Clin. Invest.
100
:
3014
5
Goodman, J. L., C. Nelson, B. Vitale, J. E. Madigan, J. S. Dumler, T. J. Kurtti, U. G. Munderloh.
1996
. Direct cultivation of the causative agent of human granulocytic ehrlichiosis.
N. Engl. J. Med.
334
:
209
6
Clark, R. A..
1999
. Activation of the neutrophil respiratory burst oxidase.
J. Infect. Dis.
179
: (Suppl. 2):
S309
7
Ambruso, D. R., B. G. Bolscher, P. M. Stokman, A. J. Verhoeven, D. Roos.
1990
. Assembly and activation of the NADPH:O2 oxidoreductase in human neutrophils after stimulation with phorbol myristate acetate.
J. Biol. Chem.
265
:
924
8
Leto, T. L., K. J. Lomax, B. D. Volpp, H. Nunoi, J. M. Sechler, W. M. Nauseef, R. A. Clark, J. I. Gallin, H. L. Malech.
1990
. Cloning of a 67 kD neutrophil oxidase factor with similarity to a non-catalytic region of p60c-src.
Science
248
:
727
9
Lomax, K. J., T. L. Leto, H. Nunoi, J. I. Gallin, H. L. Malech.
1989
. Recombinant 47 kD cytosol factor restores NADPH oxidase in chronic granulomatous disease.
Science
245
:
409
10
Parkos, C. A., R. A. Allen, C. G. Cochrane, A. J. Jesaitis.
1987
. Purified cytochrome b from human granulocyte plasma membrane is comprised of two polypeptides with relative molecular weights of 91,000 and 22,000.
J. Clin. Invest.
80
:
732
11
Clark, R. A., B. D. Volpp, K. G. Leidal, W. M. Nauseef.
1990
. Two cytosolic components of the human neutrophil respiratory burst oxidase translocate to the plasma membrane during cell activation.
J. Clin. Invest.
85
:
714
12
Roos, D., M. de Boer, F. Kuribayashi, C. Meischl, R. S. Weening, A. W. Segal, A. Ahlin, K. Nemet, J. P. Hossle, E. Bernatowska-Matuszkiewicz, H. Middleton-Price.
1996
. Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease.
Blood
87
:
1663
13
Levy, R., D. Rotrosen, O. Nagauker, T. L. Leto, H. L. Malech.
1990
. Induction of the respiratory burst in HL-60 cells: correlation of function and protein expression.
J. Immunol.
145
:
3595
14
Webster, P., J. Ijdo, L. H. Chicone, E. Fikrig.
1998
. The agent of human granulocytic ehrlichiosis resides in an endosomal compartment.
J. Clin. Invest.
102
:
1932
15
Mott, J., R. E. Barnewall, Y. Rikihisha.
1999
. Human granulocytic ehrlichiosis agent and Ehrlichia chaffeenisis reside in different cytoplasmic compartments in HL60 cells.
Infect Immun.
67
:
1368
16
Breitman, T. R., S. E. Selonick, S. J. Collins.
1980
. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid.
Proc. Natl. Acad. Sci. USA
77
:
2936
17
Heimer, R., A. V. Andel, G. P. Wormser, M. L. Wilson.
1997
. Propagation of granulocytic Ehrlichia spp. from human and equine sources in HL-60 cells induced to differentiate into functional granulocytes.
J. Clin. Microbiol.
35
:
923
18
Cassatella, M. A., F. Bazzoni, R. M. Flynn, S. Dusi, G. Trinchieri, F. Rossi.
1990
. Molecular basis of interferon-γ and lipopolysaccharide enhancement of phagocyte respiratory burst capability: studies on the gene expression of several NADPH oxidase components.
J. Biol. Chem.
265
:
20241
19
Jones, S. A., V. B. O’Donnell, J. D. Wood, J. P. Broughton, E. J. Hughes, O. T. Jones.
1996
. Expression of phagocyte NADPH oxidase components in human endothelial cells.
Am. J. Physiol.
271
:
H1626
20
Jones, W. M., B. Walcheck, M. A. Jutila.
1996
. Generation of a new gamma delta T cell-specific monoclonal antibody (GD3.5): biochemical comparisons of GD3.5 antigen with the previously described Workshop Cluster 1 (WC1) family.
J. Immunol.
156
:
3772
21
Telford, M. A., S. R. III, J. E. Dawson, P. Katavolos, C. K. Warner, C. P. Kolbert, D. H. Persing.
1996
. Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle.
Proc. Natl. Acad. Sci. USA
93
:
6209
22
Calafat, J., T. W. Kuijpers, H. Janssen, N. Borregaard, A. J. Verhoeven, D. Roos.
1993
. Evidence for small intracellular vesicles in human blood phagocytes containing cytochrome b558 and the adhesion molecule CD11b/CD18.
Blood
81
:
3122
23
Buchmuller-Rouiller, Y., J. Mauel.
1987
. Impairment of the oxidative metabolism of mouse peritoneal macrophages by intracellular Leishmania spp.
Infect. Immun.
55
:
587
24
Sahney, N. N., B. C. Lambe, J. T. Summersgill, R. D. Miller.
1990
. Inhibition of polymorphonuclear leukocyte function by Legionella pneumophila exoproducts.
Microb. Pathog.
9
:
117
25
Chang, H. R., J. C. Pechere.
1989
. Macrophage oxidative metabolism and intracellular Toxoplasma gondii.
Microb. Pathog.
7
:
37
26
Tauber, A. I., N. Pavlotsky, J. S. Lin, P. A. Rice.
1989
. Inhibition of human neutrophil NADPH oxidase by Chlamydia serovars E, K, and L2.
Infect. Immun.
57
:
1108
27
Lin, J. Y., K. Keller, K. Chadee.
1993
. Entamoeba histolytica proteins modulate the respiratory burst potential by murine macrophages.
Immunology
78
:
291
28
Williams, N. M., R. J. Cross, P. J. Timoney.
1994
. Respiratory burst activity associated with phagocytosis of Ehrlichia risticii by mouse peritoneal macrophages.
Res. Vet. Sci.
57
:
194